CTVA vs QURE · P/E 42, rev $16.91B vs rev $16.1M
Corteva Inc (CTVA) versus Uniqure NV (QURE) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. QURE currently screens at market cap $3.04B.
Not investment advice. Open the CTVA and QURE stock pages for the full models.
Not investment advice.